Explore Evolent Health’s Q4 2025 earnings: $468.7 m revenue, 30 % growth, $151 m adjusted EBITDA, and a 2026 outlook with projected margin expansion and new high‑profile health‑plan partnerships.
Discover why Evolent Health’s stock dipped below its 50‑day moving average, its valuation surprises, and how its value‑based care platform still drives innovation in healthcare technology.